Most bought healthcare stocks in Q2 2016
See which Healthcare stocks institutional investors increased the most in Q2 2016, measured as net growth in reported share positions from Q1 2016 into Q2 2016. Notable additions at the top of this list include ASTRAZENECA PLC-SPONS ADR (AZN), BOSTON SCIENTIFIC CORP (BSX), CVS HEALTH CORP (CVS), BIOGEN INC (BIIB). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLC-SPONS ADR | 6,766,373 | $268.74M | 0 | 2 | 0 | 0 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | 4,240,980 | $104.03M | 0 | 1 | 2 | 0 | 3 |
| CVS | CVS HEALTH CORP | 4,016,681 | $335.39M | 0 | 6 | 1 | 1 | 10 |
| BIIB | BIOGEN INC | 3,489,587 | $849.49M | 1 | 2 | 2 | 0 | 6 |
| MRK | MERCK & CO. INC. | 2,613,113 | $283.20M | 1 | 7 | 4 | 1 | 14 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2,321,342 | $127.25M | 1 | 0 | 1 | 0 | 2 |
| DVA | DAVITA INC | 1,867,026 | $328.79M | 0 | 2 | 2 | 0 | 5 |
| SNY | SANOFI-ADR | 1,654,207 | $167.33M | 1 | 3 | 0 | 0 | 6 |
| PDCO | PATTERSON COS INC | 1,063,745 | $61.93M | 1 | 2 | 1 | 0 | 5 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,047,065 | $8.07M | 0 | 2 | 4 | 0 | 8 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 986,965 | $39.54M | 0 | 1 | 0 | 1 | 1 |
| ABBV | ABBVIE INC | 884,104 | $62.31M | 2 | 3 | 3 | 0 | 11 |
| WAT | WATERS CORP | 791,038 | $141.10M | 0 | 1 | 1 | 1 | 3 |
| PRGO | Perrigo Company PLC | 759,954 | -$156.50M | 1 | 2 | 0 | 1 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 721,600 | $32.92M | 0 | 1 | 0 | 0 | 1 |
| BRKR | BRUKER CORP | 711,400 | $13.86M | 0 | 1 | 0 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | 704,180 | $5.47M | 1 | 2 | 0 | 0 | 3 |
| EW | EDWARDS LIFESCIENCES CORP | 553,875 | $101.24M | 0 | 2 | 0 | 0 | 2 |
| ARAY | ACCURAY INC | 537,600 | $1.15M | 0 | 1 | 0 | 0 | 1 |
| BMY | BRISTOL-MYERS SQUIBB CO | 509,901 | $37.23M | 1 | 1 | 4 | 0 | 10 |
| HAE | HAEMONETICS CORP/MASS | 500,100 | $12.84M | 0 | 1 | 0 | 0 | 1 |
| ENZ | ENZO BIOCHEM INC | 417,081 | $4.55M | 0 | 1 | 0 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | 415,275 | $3.11M | 0 | 1 | 0 | 1 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | 405,200 | -$1.16M | 0 | 1 | 0 | 0 | 1 |
| PODD | INSULET CORP | 398,492 | $11.40M | 0 | 1 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 393,200 | $12.56M | 0 | 1 | 0 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | 358,557 | $100.94M | 0 | 2 | 0 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | 299,384 | $50.28M | 0 | 2 | 1 | 0 | 3 |
| XRAY | DENTSPLY SIRONA INC | 264,083 | $16.51M | 1 | 2 | 0 | 0 | 3 |
| CAH | CARDINAL HEALTH INC | 216,296 | -$9.15M | 0 | 4 | 0 | 0 | 4 |
| GILD | GILEAD SCIENCES INC | 192,715 | -$143.98M | 1 | 8 | 6 | 0 | 15 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 178,532 | $4.36M | 0 | 2 | 0 | 0 | 2 |
| AXGN | AXOGEN INC | 174,700 | $1.20M | 1 | 0 | 0 | 0 | 1 |
| NEO | NEOGENOMICS INC | 172,500 | $1.82M | 0 | 1 | 0 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | 161,400 | -$4.62M | 0 | 1 | 0 | 0 | 1 |
| PEN | PENUMBRA INC | 158,600 | $9.44M | 1 | 0 | 0 | 0 | 1 |
| VCEL | VERICEL CORP | 152,954 | -$516.00K | 0 | 1 | 0 | 0 | 1 |
| LAB | STANDARD BIOTOOLS INC | 152,100 | $1.48M | 0 | 1 | 0 | 0 | 1 |
| RGEN | REPLIGEN CORP | 142,400 | $4.43M | 0 | 1 | 0 | 0 | 1 |
| GKOS | GLAUKOS CORP | 124,400 | $3.63M | 1 | 0 | 0 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 123,700 | $1.86M | 0 | 1 | 0 | 0 | 1 |
| AMN | AMN HEALTHCARE SERVICES INC | 110,600 | $5.31M | 0 | 1 | 0 | 0 | 1 |
| MCK | MCKESSON CORP | 104,908 | $54.95M | 3 | 1 | 1 | 1 | 7 |
| LNTH | LANTHEUS HOLDINGS INC | 99,300 | $364.00K | 1 | 0 | 0 | 0 | 1 |
| PFMT | PERFORMANT FINANCIAL CORP | 97,900 | $117.00K | 0 | 1 | 0 | 0 | 1 |
| ENTA | ENANTA PHARMACEUTICALS INC | 96,600 | $1.72M | 0 | 1 | 0 | 0 | 1 |
| CHRS | COHERUS BIOSCIENCES INC | 94,500 | $1.60M | 1 | 0 | 0 | 0 | 1 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 91,400 | $3.98M | 1 | 0 | 0 | 0 | 1 |
| NTRA | NATERA INC | 85,800 | $1.03M | 1 | 0 | 0 | 0 | 1 |
| NVRO | NEVRO CORP | 85,500 | $6.31M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2016
What are the most bought Healthcare stocks in Q2 2016?
The most bought healthcare stocks in Q2 2016 are those with the largest increase in reported share counts across institutional investors compared to Q1 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2016?
Among filers in this sector, net additions were largest in companies such as ASTRAZENECA PLC-SPONS ADR (AZN), BOSTON SCIENTIFIC CORP (BSX), CVS HEALTH CORP (CVS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.